Inhibitors of bacterial H2S biogenesis targeting antibiotic resistance and tolerance
- PMID: 34112687
- PMCID: PMC10723041
- DOI: 10.1126/science.abd8377
Inhibitors of bacterial H2S biogenesis targeting antibiotic resistance and tolerance
Abstract
Emergent resistance to all clinical antibiotics calls for the next generation of therapeutics. Here we report an effective antimicrobial strategy targeting the bacterial hydrogen sulfide (H2S)-mediated defense system. We identified cystathionine γ-lyase (CSE) as the primary generator of H2S in two major human pathogens, Staphylococcus aureus and Pseudomonas aeruginosa, and discovered small molecules that inhibit bacterial CSE. These inhibitors potentiate bactericidal antibiotics against both pathogens in vitro and in mouse models of infection. CSE inhibitors also suppress bacterial tolerance, disrupting biofilm formation and substantially reducing the number of persister bacteria that survive antibiotic treatment. Our results establish bacterial H2S as a multifunctional defense factor and CSE as a drug target for versatile antibiotic enhancers.
Copyright © 2021 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.
Conflict of interest statement
Figures





Comment in
-
Giving antibiotics an assist.Science. 2021 Jun 11;372(6547):1153. doi: 10.1126/science.abj3062. Science. 2021. PMID: 34112683 No abstract available.
-
Giving antibiotics a boost.Nat Rev Drug Discov. 2021 Aug;20(8):585. doi: 10.1038/d41573-021-00112-9. Nat Rev Drug Discov. 2021. PMID: 34158669 No abstract available.
References
-
- Payne DJ, Gwynn MN, Holmes DJ, Pompliano DL, Drugs for bad bugs: confronting the challenges of antibacterial discovery. Nat Rev Drug Discov 6, 29–40 (2007). - PubMed
-
- O’Neill J, “Tackling drug-resistant infections globally: Final report and recommendations “ (2016).
-
- Brauner A, Fridman O, Gefen O, Balaban NQ, Distinguishing between resistance, tolerance and persistence to antibiotic treatment. Nat Rev Microbiol 14, 320–330 (2016). - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical